Skip to main content
News > News > Open Therapeutics and doDOC™ Partner to Integrate doDOC™ Content Management System into Therapoid™.

Open Therapeutics and doDOC™ Partner to Integrate doDOC™ Content Management System into Therapoid™.

Open Therapeutics and doDOC™ Partner to Integrate doDOC™ Content Management System into Therapoid™.

 

Innovative manuscript development tool to be integrated into scientific collaboration platform.

 

Minneapolis, MN and Boston, MA – June 27, 2018 – Open Therapeutics LLC, a scientific collaboration platform company, and doDOC, a online collaborative writing tool that allows researchers to plan, draft, edit, review and approve professional documents more than 70% faster, have partnered. Therapoid™ will freely provide its scientific users with the web-based doDOC scientific manuscript development tool.

 

According to Jerome Hamilton, CEO of Open Therapeutics, “The Therapoid™ scientific collaboration platform is being designed to provide researchers an end-to-end scientific ecosystem experience.  After providing scientists with free therapeutic intellectual properties to collaborate around, it is important to enable those researchers to develop manuscripts they can submit to our preprint server so open access journals can review them for publication”.

 

According to Federico Cismondi, CEO of doDOC, “doDOC is helping researchers collaborate with scientific manuscripts in a way they have never experienced before. doDOC enables teams to work together on the same documents at the same time, drastically accelerating the authoring and review processes. With doDOC, scientists can write documents with the highest complexity of contents, seamlessly using citations from several popular repositories like Mendeley, PubMed, Scopus and EndNote. Our partnership with Open Therapeutics is aligned with our vision to define the next generation of scientific collaboration platforms, with complete focus on science development, high-quality content and value.”

 

The Therapoid™ platform is in alpha release at https://Therapoid.net.  The doDOC tool integration into Therapoid™ should be completed in Q4 2018 and will be free to researchers.

 

About Open Therapeutics LLC

Open Therapeutics (http://OpenTherapeutics.org) is an intellectual property firm that creates and attracts therapeutic technologies and crowdsources them for use by the global scientific community. Researchers can freely access the intellectual properties, funding, lab equipment, manuscript development tool, and preprint server to further the development of the therapeutic technologies (medical devices, pharma, diagnostics) at Therapoid™ (https://Therapoid.net). The Company is headquartered in Minneapolis, MN, with operations in Cincinnati, OH, Amman, Jordan, and Bangalore, India.

 

Contact: Jerome Hamilton, CEO, Open Therapeutics

+1.651.900.0412

Jerome@OpenTherapeutics.org

Twitter: @OpenTherapeutic

Telegram: https://t.me/OpenTherapeutics

 

About doDOC Corp.

doDOC’s mission is to change the way that complex documents are produced, from draft to publishing. Scientific documents are among the most complex ones due to their contents and strict layout design. With doDOC, scientists not only save time, but they also produce higher quality of publications due to an open channel for collaboration with their colleagues, full traceability and control of their actions, and a virtually infinite library of citations and layouts following journals specifications. doDOC is a powerful and flexible cloud-based software, scaled to meet the needs of any business, from startups to global companies.

 

Contact:
Federico Cismondi, CEO

+1.617.806.6635

sales@dodoc.com
https://dodoc.com/

Twitter: @doD0C

Our Effort

Open Therapeutics is a major backer of open science and open access efforts.

Open Therapeutics freely provides to science, technology, engineering, and math (STEM) scientists, or another other seriously interested persons, intellectual properties (patents, etc.), grant funding, lab equipment, document development tools, and preprint server in a collaboration platform (Therapoid™).

When the researchers advance the intellectual properties, s/he gains ScienceCoins™; a blockchain-based cryptocurrency.

Please read our Open Therapeutics’ company whitepaper.

Secured By miniOrange